Professional Documents
Culture Documents
EMERGING APPLICATIONS
OF CARBON NANOTUBES IN
DRUG AND GENE DELIVERY
Edited by
PRASHANT KESHARWANI
Assistant Professor, Department of Pharmaceutics,
School of Pharmaceutical Education and Research,
Jamia Hamdard, New Delhi, India
Woodhead Publishing is an imprint of Elsevier
50 Hampshire Street, 5th Floor, Cambridge, MA 02139, United States
The Boulevard, Langford Lane, Kidlington, OX5 1GB, United Kingdom
Notices
Knowledge and best practice in this field are constantly changing. As new research
and experience broaden our understanding, changes in research methods, professional
practices, or medical treatment may become necessary.
Practitioners and researchers must always rely on their own experience and knowledge
in evaluating and using any information, methods, compounds, or experiments
described herein. In using such information or methods they should be mindful of
their own safety and the safety of others, including parties for whom they have a
professional responsibility.
To the fullest extent of the law, neither the Publisher nor the authors, contributors, or
editors, assume any liability for any injury and/or damage to persons or property as a
matter of products liability, negligence or otherwise, or from any use or operation of
any methods, products, instructions, or ideas contained in the material herein.
ISBN: 978-0-323-85199-2
ix
x Contributors
Duygu Harmanci
Central Research Test and Analysis Laboratory Application and Research Center, Ege
University, Bornova, Izmir, Turkey
Gowtham Kenguva
Department of Industrial and Engineering Chemistry, Institute of Chemical Technology
Mumbai-Indian Oil Odisha Campus, Bhubaneswar, Odisha, India
Prashant Kesharwani
Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia
Hamdard, New Delhi, Delhi, India; University Institute of Pharma Sciences, Chandigarh
University, Mohali, Punjab, India
Renat R. Khaydrov
Institute of Nuclear Physics, Uzbekistan Academy of Sciences, Tashkent, Uzbekistan
Majid Khazaei
Department of Physiology, Faculty of Medicine, Mashhad University of Medical Science,
Mashhad, Iran; Metabolic Syndrome Research Centre, Mashhad University of Medical
Science, Mashhad, Iran
Praveen T. Krishnamurthy
Department of Pharmacology, JSS College of Pharmacy (JSS Academy of Higher
Education & Research), Ooty, Tamil Nadu, India
G. Kusuma Kumari
Department of Pharmacology, JSS College of Pharmacy (JSS Academy of Higher
Education & Research), Ooty, Tamil Nadu, India
Javier Lara-Romero
Facultad de Ingeniería Química, Universidad Michoacana de San Nicolás de Hidalgo,
Morelia, Michoacán, México
Ahmed R. Mahmood
Department of Medical Laboratory Technology, Imam Ja’afar Al-Sadiq University,
Kirkuk, Iraq
Abdulwahhab H. Majeed
Department of Chemistry, College of Science, Diyala University, Diyala, Iraq
Leqaa A. Mohammed
Department of Chemistry, College of Science, Diyala University, Diyala, Iraq
Seyedeh Elnaz Nazari
Department of Physiology, Faculty of Medicine, Mashhad University of Medical Science,
Mashhad, Iran
Ammu V.V. V. Ravi Kiran
Department of Pharmacology, JSS College of Pharmacy (JSS Academy of Higher
Education & Research), Ooty, Tamil Nadu, India
Majid Rezayi
Medical Toxicology Research Centre, Mashhad University of Medical Science, Mashhad,
Iran; Metabolic Syndrome Research Centre, Mashhad University of Medical Science,
Contributors xi
1.1 Introduction
Biotechnology researchers have developed a keen interest toward nano-
technology and have been focusing on working with nanomaterials in
recent decades [1,2]. Because of their unique properties, nanomaterials are
particularly well-suited for biomedical applications. They are facile to
synthesize, can be modified in size, contain tunable surface chemistry,
provide large surface-to-volume ratios, and are generally biocompatible [3].
All of these features make nanomaterials promising for almost all aspects of
biotechnology, overcoming the many shortcomings in existing conven-
tional materials [4]. Following a pioneering study by Higuchi et al. on
albumin nanoparticles, it was suggested that nanomedicine could be an
effective tool to target tumors and cancer cells as the ability to avoid im-
mune system clearance is enhanced [5]. Nanoparticles have shown to have
positive results against coronary artery disease, and cancer cells, by effec-
tively avoiding clearance from immune system clearance [6e9]. Nano-
particles can be used to deliver a large variety of pharmaceuticals in a way
that is safer (through targeted nanomedicines by limiting the amount of
drug delivered) and more effective [10]. Biological and medical nano-
materials have been used for years, including liposomes [11], carbon
nanoparticles [12e17], dendrimers [18], ceramic nanoparticles [19], iron
oxide nanoparticles [20], titanium dioxide nanoparticles [21], magnetic
nanoparticles, polymer nanocomposites [18], silica and metal nanoparticles
[22]. Additionally, many different types of nanomaterials have been
Emerging Applications of Carbon Nanotubes in Drug and Gene Delivery
ISBN 978-0-323-85199-2 © 2023 Elsevier Ltd.
https://doi.org/10.1016/B978-0-323-85199-2.00009-1 All rights reserved. 1
2 Emerging Applications of Carbon Nanotubes in Drug and Gene Delivery
Therapeutical application
Photothermal CNTs would produce heat by converting [33]
therapy near-infrared radiation (NIR).
Drug delivery The unique needle-like shape of carbon [34]
nanotubes with the ability to quickly
penetrate cell membranes makes them ideal
carriers of drugs/genes due to their high
surface area, multifunctional surface
chemistry, lack of immunogenicity, and high
surface area.
Tissue Carbon nanotubes can be used in tissue [35]
engineering engineering because of their
biocompatibility, stiffness, mimicking of
natural tissue nanofibers, cell adhesion and
proliferation stimulation, and ability to form
3D structures.
Lab-on-chip- Miniaturized systems such as lab-on-a-chip [36]
devices devices are used to examine drugs, grow
cells, and model diseases using tiny volumes
of fluid flowing in various channels. The
CNTs would be used in LOC devices as
membrane channels, sensors, and channels
walls.
Record identified throughout database including: Google Scholar 70300, Scupos 125277,
WOS 189358, PubMed 1353
searching n= 386288, 347292 Duplicates removed
1846 Articles
11 Review papers
201 Letters
149 Conference papers
(a) (b)
600 Conference
Paper
3%
500 Book
Chapter Article
6%
400 Review
Book Chapter
300 Article Conference
Review 52% Paper
200 36% Editorial
Conference
100 Review
(c)
Figure 1.2 (a) The network of keywords, (b) clustering of keywords, and (c) categories
of the subject area, and inset categories by article type.
(a)
16%
14%
12%
10%
8%
6%
4%
2%
0%
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
(b)
Figure 1.3 (a) Trend topic growth between 2012 and 2022, and (b) average article
published per year time span 2012e22.
8 Emerging Applications of Carbon Nanotubes in Drug and Gene Delivery
Figure 1.4 Publication of carbon nanotube in drug delivery system research papers:
top countries and clusters (a and b), and (c) three-field plot of top-author, top-
countries; and top authors’ keywords on the considered topic.
Armchair
Zigzag
Figure 1.6 Schematic illustration of cisplatin delivery system and possible internali-
zation method of carbon nanotube including loading of the drug on the surface of
carbon nanotube, then cisplatin carried inside, in vivo study of current nanocarrier and
pH-responsive releasing drug leading to decreasing of tumor size.
Background of carbon nanotubes for drug delivery systems 15
CNTs and their cellular uptake have been analyzed using a wide range
of techniques, including atomic force microscopy, transmission electron
microscopy, dynamic light scattering, fluorescence microscopy, surface-
enhanced Raman scattering, and confocal Raman spectroscopy. The
characterization and visualization of cellular uptake of CNTs are based on
some characteristics of CNTs, such as optical characteristics [107e109]. The
evolution of nanotechnology began with improvements in microscopy, and
this here depicts is no lesser truth in terms of CNT cellular
internationalization.
CNTs are used as drug carriers to reduce side effects by preventing the
deactivation of therapeutic agents. In one study, the synthesis of func-
tionalized SWCNTs containing cisplatin to target prostate cancer cell lines
PC3 and DU145 was reported. Cisplatin acts by penetrating deep within
the cellular membrane and selectively accumulating within the cytoplasm of
cancerous prostate cells based on findings of cellular uptake studies.
Therefore, the encapsulation of cisplatin has proved to be very effective
factor in stabilizing its administration to cancerous prostate cells [118].
It has also been extensively used for treating cancer with doxorubicin
drug as an anticancer therapeutic agent. The chemical structure of doxo-
rubicin has been shown in (Fig. 1.4b). The non-covalent complexation of
MWCNTs and functionalized SWCNTs with polyethylene glycol (PEG)
was also demonstrated by Hwang [119]. In an investigation, it was found
that MWCNTs combined with doxorubicin work better against cancerous
cells than doxorubicin alone. SWCNTs have been synthesized and modi-
fied with different types of polysaccharides as well as with doxorubicin and
folic acid in recent years [120]. In some cases, the release of therapeutic
agents from within these nanocarriers was reported to be pH dependent. In
this regard, CNTs are functionalized on the surface to control the rate of
drug release and loading efficiency. According to Fabbro et al. research
[116], a novel method is essential for improving the construction and
characterization of modified CNTs to allow them to be applied
therapeutically.